Canopy Growth Corporation (TSX:WEED)
Canada
· Delayed Price · Currency is CAD 1.580
-0.060 (-3.66%)
Apr 28, 2026, 4:00 PM EST
Canopy Growth Revenue
Canopy Growth had revenue of 74.54M CAD in the quarter ending December 31, 2025, a decrease of -0.29%. This brings the company's revenue in the last twelve months to 278.39M, up 0.59% year-over-year. In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M, down -9.47%.
Revenue (ttm)
278.39M
Revenue Growth
+0.59%
P/S Ratio
2.16
Revenue / Employee
289.99K
Employees
960
Market Cap
601.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.13B |
| Knight Therapeutics | 450.09M |
| Cresco Labs | 899.24M |
| Cipher Pharmaceuticals | 69.17M |
| DRI Healthcare Trust | 263.00M |
| TerrAscend | 357.26M |
| Organigram Global | 279.99M |
| Aurora Cannabis | 373.12M |
Canopy Growth News
- 1 day ago - Canopy Growth Stock Is Jumping. Is It Overdue for a Much Bigger Rally? - The Motley Fool
- 4 days ago - Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce? - The Motley Fool
- 4 days ago - Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change - Benzinga
- 5 days ago - 'Big Business Opportunity': Cannabis CEO Celebrates DOJ Easing Regulations On Medical Marijuana - Forbes
- 5 days ago - The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off - Market Watch
- 5 days ago - Cannabis Stocks Soared—Than Sank. Here's What Investors Need to Know. - Investopedia
- 5 days ago - Cannabis rescheduling fuels optimism across industry - Reuters
- 5 days ago - What's Going On With Canopy Growth Stock Thursday? - Benzinga